Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Jun 15, 2026Jun 11, 2026Moore David ScottDirectorPPurchaseCommon Stock+21.7K$11.53+$250.2K21.7KNew positionSEC
May 20, 2026May 18, 2026MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+6.93K$12.0389+$83.45K1.2M+0.6%SEC
Jul 1, 20259:23 PM ETJun 27, 2025ORBIMED ADVISORS LLC and 1 otherDirector, 10% OwnerSSaleCommon Stock−1.18M$4.1586−$4.89M7.17M−14.1%SEC
Jul 1, 2025Jun 27, 2025Thompson Peter A.Director, 10% OwnerSSaleCommon Stock−1.18M$4.16−$4.89M7.17M−14.1%SEC
May 8, 20248:28 PM ETMay 6, 2024ORBIMED ADVISORS LLC and 1 otherDirector, 10% OwnerPPurchaseCommon Stock · Derivative+2.84M$1.7311+$2.5M1.4M–SEC
May 8, 2024May 6, 2024Thompson Peter A.Director, 10% OwnerPPurchaseCommon Stock · Derivative+2.84M$1.73+$2.5M1.4M–SEC
May 7, 2024May 6, 2024Jones William BentonSee RemarksPPurchaseCommon Stock+20K$1.73+$34.6K153.77K+15.0%SEC
May 7, 2024May 6, 2024Jones William BentonSee RemarksPPurchaseCommon Stock · Derivative+19.36K––19.36K–SEC
May 7, 2024May 6, 2024MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+577.63K$1.73+$999.31K577.63KNew positionSEC
May 7, 2024May 6, 2024MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock · Derivative+559.07K––559.07K–SEC
May 16, 2023May 15, 2023Grais LindaDirectorPPurchaseCommon Stock+10K$2.45+$24.5K10KNew positionSEC
Dec 20, 2022Dec 20, 2022Jones William BentonSee RemarksPPurchaseCommon Stock+20K$0.79+$15.8K133.77K+17.6%SEC
Dec 15, 2022Dec 13 – Dec 14, 2022LEA LEIVChief Financial OfficerPPurchaseCommon Stock+34K$0.7518+$25.56K133.24K+34.3%SEC
Dec 15, 2022Dec 13 – Dec 14, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+60K$0.7467+$44.8K1.49M+4.2%SEC
Sep 28, 2022Sep 28, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+25K$0.76+$19K1.39M+1.8%SEC
Sep 20, 2022Sep 20, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+20K$0.8139+$16.28K1.37M+1.5%SEC
Jun 28, 2022Jun 24 – Jun 27, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+10K$1.015+$10.15K1.35M+0.7%SEC
Jun 6, 2022Jun 2 – Jun 6, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+5.89K$0.9842+$5.8K1.34M+0.4%SEC
Apr 1, 2022Mar 31, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+15K$1.64+$24.6K1.33M+1.1%SEC
Mar 17, 2022Mar 16 – Mar 17, 2022LEA LEIVChief Financial OfficerPPurchaseCommon Stock+49.04K$1.5711+$77.05K99.24K+97.7%SEC
Mar 17, 2022Mar 15 – Mar 17, 2022MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+30K$1.49+$44.7K1.32M+2.3%SEC
Oct 1, 2021Sep 30 – Oct 1, 2021EcoR1 Capital, LLC10% OwnerSSaleCommon Stock−5M$5.008−$25.04M81.08K−98.4%SEC
Sep 22, 20215:27 PM ETSep 20, 2021ORBIMED ADVISORS LLC and 1 otherDirector, 10% OwnerSSaleCommon Stock, $0.0001 par value−1.11M$6.09−$6.76M6.94M−13.8%SEC
Sep 22, 2021Sep 20, 2021Thompson Peter A.Director, 10% OwnerSSaleCommon Stock, $0.0001 par value−1.11M$6.09−$6.76M6.94M−13.8%SEC
Aug 23, 2021Aug 20, 2021MILLER RICHARD A MDPresident and CEOPPurchaseCommon Stock+10K$1.93+$19.3K1.29M+0.8%SEC